TGODF - The Green Organic Dutchman Holdings Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD
+0.1883 (+6.56%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.8700
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.8600 - 3.1000
52 Week Range1.6070 - 7.8940
Avg. Volume1,170,012
Market Cap857.445M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1270
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Green Organic Dutchman (TGODF) Stock — Not Sinking Exactly, But Not Sailing Anywhere Fast

    The Green Organic Dutchman (TGODF) Stock — Not Sinking Exactly, But Not Sailing Anywhere Fast

    Canadian cannabis company The Green Organic Dutchman (TGODF) reported fiscal Q1 2019 earnings late Tuesday. It's Monday now and, if this is the first you've heard of the news -- don't be surprised. "TGOD" didn't exactly make a lot of headlines with its earnings news, and investors mostly slept through the report.TGOD stock was up a mere 1.4% on Wednesday after the report ... and flatlined on Thursday and Friday -- no change at all.Why so little fanfare? After all, didn't TGOD grow its sales 28% year over year in Q1?Well, yes, it did. However, even that strong growth rate still left TGOD selling little more than a corporate-scale dime bag of product for the quarter -- $2.4 million, to be precise. And TGOD didn't even make a profit on the transaction. To the contrary, TGOD reported a $14.1 million net loss in Q1, "as it continues its preparation for commercial production and entry into the recreational market later this year," said management.So how did Wall Street analysts react to the report? Well, let's see here. Seaport Global's Brett Hundley, which has taken a keen interest in Canadian pot stocks of late, opined that TDOG's miniscule sales were at least "in line with expectations for Q1," while the company's "EBITDA loss ... was slightly worse than anticipated.""No matter," though, said Hundley (his words, not ours). Because in the analyst's view, "reported results are largely immaterial and much of the forward focus for this company remains on the potential for forward commercialization and consumer adoption."Hundley, it seems, is viewing TGOD not so much as a business (which is, you know, supposed to make sales and earn profit) as his is seeing the company as a story stock -- which only really needs to tell a compelling tale to attract investor interest. And in this regard, the analyst sees TGOD as succeeding: * TGOD "remains on track for its build-out of facilities." (Translation: It hasn't built a lot of facilities yet). * And TGOD "intends to enter the Canadian adult-use market in ON and BC during Q4, before expanding nationally in 2020." (Translation: It hasn't yet managed to break into the Canadian adult-use market -- nationally or otherwise). * Perhaps most tellingly of all, Hundley notes that of the $2.4 million in sales TGOD did make during the quarter, these sales were "primarily derived from the company's HemPoland subsidiary, consistent with Q4."And if you recall, TGOD bought HemPoland last August, so most of the sales the company made... came from another company that it bought.If all of the above has you wondering what it is, exactly, that Hundley sees in TGOD that merits a "buy" rating (and the analyst does indeed recommend buying TGOD stock), well, you're not alone. A lot of investors yesterday and the day before seem to have wondered the same thing. That being said, there is one small factor to consider that may shed a ray of hope for TGOD bulls.To wit, TGOD operates in the high-margin "organic" segment of the marijuana market, and Hundley says it's been successful selling organic marijuana flower for as much as $12 a gram (and other pot companies have gotten even better prices). Considering that TGOD eventually hopes to produce organic marijuana for as little as $1 a gram, that seems to offer a lot of room for robust profit margins.Whether those margins will ever be robust enough to justify TGOD's current valuation of 247 times sales, of course, remains to be seen.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Read more on TGOD: The Green Organic Dutchman Offers the Best Value for Investors More recent articles from Smarter Analyst: * Tesla (TSLA) Stock Isn't a Bargain, Despite Recent Sell-Off, Says Needham * Micron (MU) Stock Remains a Long-Term Buy, Says Analyst * The Clouds Are Getting Darker for Tesla (TSLA) Stock * OrganiGram: An Under the Radar Cannabis Stock to Be Listed on the Big Board Today

  • Green Organic Dutchman’s Losses Narrow as Revenue Rises in Q1
    Market Realist6 days ago

    Green Organic Dutchman’s Losses Narrow as Revenue Rises in Q1

    Green Organic Dutchman's Losses Narrow as Revenue Rises in Q1TGOD Q1 earningsGreen Organic Dutchman Holdings (TGOD) (TGODF) reported its first-quarter earnings yesterday after the markets closed. It reported revenues of $2.4 million in the quarter,

  • The Green Organic Dutchman Reports Q1 Fiscal 2019 Results
    PR Newswire7 days ago

    The Green Organic Dutchman Reports Q1 Fiscal 2019 Results

    TORONTO, May 14, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to report its financial and operational results for the three months ended March 31, 2019. Is on-track with construction at Hamilton and Valleyfield sites, with investment amounting to $46.9 million in the first quarter of 2019, an increase of $7.4 million compared to $39.5 million incurred in the fourth quarter 2018. Launched its Grower's Circle on March 25th, 2019, commencing direct to patient medical sales in Canada with products from its existing Hamilton facility.

  • How TGOD’s Valuation Compares with Its Peers
    Market Realist7 days ago

    How TGOD’s Valuation Compares with Its Peers

    TGOD Obtains Approval for Cultivation at Its Hamilton Building(Continued from Prior Part)Valuation multipleThe surge in The Green Organic Dutchman Holdings’ (TGOD)(TGODF) stock price since the beginning of 2019 has raised its valuation multiple.

  • TGOD Obtains Approval for Cultivation at Its Hamilton Building
    Market Realist7 days ago

    TGOD Obtains Approval for Cultivation at Its Hamilton Building

    TGOD Obtains Approval for Cultivation at Its Hamilton BuildingThe announcementToday, The Green Organic Dutchman Holdings (TGOD)(TGODF) announced that it received approval from Health Canada for cultivation at its facility in Hamilton, Ontario. The

  • TGOD Receives Health Canada Approval to Start Cultivation Operations at New Hamilton Building
    PR Newswire7 days ago

    TGOD Receives Health Canada Approval to Start Cultivation Operations at New Hamilton Building

    TORONTO, May 14, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new state-of-the-art building located in Hamilton, Ontario. "This is yet another important milestone for our team as we continue to ramp up production with a focus on executional excellence," commented Brian Athaide, CEO of TGOD. "We have pioneered the concept of sustainably growing all-natural, certified organic cannabis at scale.

  • TGOD Enters German CBD Market, Inks Distribution Agreement with Mediakos
    PR Newswire8 days ago

    TGOD Enters German CBD Market, Inks Distribution Agreement with Mediakos

    TORONTO, May 13, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (TGOD) (TGOD.TO) (TGODF) is pleased to announce that its wholly owned subsidiary, HemPoland, has entered into an agreement with Mediakos UG haftungsbeschraenkt (Mediakos) to be the exclusive distributor of CannabiGold, its premium hemp CBD brand, for the German pharmacy market. Mediakos UG spun out of, a leading German online pharmacy, and is managed by a team of seasoned industry executives with demonstrated expertise in marketing and distribution of health and wellness products. It currently distributes a broad portfolio of products to a network of more than 15,000 pharmacies and can capitalize on over 10 million customers.

  • 5 under-the-radar marijuana stocks that could pay off
    MarketWatch11 days ago

    5 under-the-radar marijuana stocks that could pay off

    The first stories trumpeting the business opportunities in marijuana started popping up around 2016, as ballot initiatives that year legalized recreational marijuana in California, Nevada, Maine and Massachusetts. Most notably, $4 billion marijuana leader Cronos Group (CRON)(CA:CRON)  has plunged more than 40% from its recent highs. Yes, there are also a bunch of microcap marijuana stocks out there that are incredibly risky.

  • TGOD Secures Supply Agreement with British Columbia
    CNW Group12 days ago

    TGOD Secures Supply Agreement with British Columbia

    TGOD Secures Supply Agreement with British Columbia

  • The Green Organic Dutchman Enters US Market Through Cornerstone Investment in Califormulations LLC
    CNW Group13 days ago

    The Green Organic Dutchman Enters US Market Through Cornerstone Investment in Califormulations LLC

    TORONTO , May 8, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce the Company's strategic investment into the US beverage space as a co-founding investor and strategic partner in the newly formed Califormulations LLC ("Califormulations"). Califormulations will operate out of Columbus, Georgia serving global branded companies with concept-to-shelf beverage commercialization support including formulation development, technical services, in-house pilot scale production and contract manufacturing co-ordination. TGOD will work with Califormulations to expedite the US launch of TGOD branded organic hemp-based CBD beverages, as local laws and regulations permit.

  • TipRanks14 days ago

    These 2 Cannabis Stocks Will be the Global Leaders In 5 Years, Says Analyst

    Jefferies analyst Owen Bennett has just released a very valuable report concerning cannabis stocks. What’s interesting is that he distinguishes between the stocks that will be dominating the market in five years’ time, and the stocks where investors can find the best value right now. “On a five-year view we continue to believe that Canopy and Aurora will be the global leaders,” Bennett told investors on Friday. However, on a 12 months basis, the analyst believes two smaller Canadian producers, The Green Organic Dutchman Holdings and CannTrust Holdings, currently offer the best value for investors. Let’s take a closer look at how these four stocks measure up now: Global Leaders Canopy Growth Corp (NYSE:CGC) (TSE:WEED)Despite his confidence in Canopy’s leadership position, Bennett nonetheless has a ‘Hold’ rating on the world’s largest cannabis company. He ascribes this rating to CGC’s current high valuation. However, if it comes to picking between Canopy and Aurora, the analyst is clear which stock he prefers:“Since initiation, we have argued that Canopy, along with Aurora, is best placed to dominate on a global basis in the years ahead. The Acreage deal further supports this view, giving Canopy a route to participation in the world's largest market, and, for us, now gives Canopy a notable advantage over Aurora in terms of its long term outlook” writes Bennett. Canopy recently announced a $3.4 billion acquisition of New York-based marijuana stock Acreage Holdings. The deal would go through as soon as cannabis has been fully legalized in the US. And with this in mind, the analyst ramps up his price target from C$64 to $C77 (17% upside potential). On the back of this deal, Canopy is now the only name in the analyst’s coverage which captures US (psychoactive) cannabis exposure in the price target.He continues: “Despite Canopy's strong global positioning, and the additional value creation to potentially come via the Acreage deal, we think this is appropriately reflected in the current price, the stock up >20% since the Acreage news broke (and 80% YTD). As such we maintain our Hold rating.”However it is worth noting that the Acreage deal, although agreed by the two companies, still requires shareholder consent. And activist investor Marcato Capital is fighting the proposed takeover, arguing that the company is worth much more than the agreed $3.4 billion. Marcato owns a 2.7% stake in Acreage. “We believe Acreage’s strategic value, as one of the few multi-state operators of scale in the U.S., with leading positions in the most valuable markets merits a significant premium to any stand-alone cash-flow derived valuation,” Marcato Capital wrote in an open letter to the board. “Furthermore, we believe enterprise values of cannabis companies will skyrocket upon the relaxation of current Federal restrictions.“Accordingly, Marcato believes it is highly imprudent for Acreage to sell itself today at the proposed valuation, with so much unlocked growth and value embedded in the company.” Shareholders will vote on the deal on June 19. Overall, the marijuana grower boasts a cautiously optimistic Moderate Buy analyst consensus. That’s with an average analyst price target of $60 (22% upside potential). We can also see that under the Canadian ticker, the average analyst share price works out at C$76.88. See what other Top Analysts are saying about CGC. Aurora Cannabis Inc (NYSE:ACB) (TSE:ACB)Bennett has a more bullish Buy rating on Canadian cannabis producer Aurora. “Despite a recent good run (up 75% YTD and 29% since late February), we still believe Aurora's current valuation looks compelling relative to true global peers” explains Bennett. “We believe Aurora, along with Canopy, is best placed to dominate globally in the years ahead, yet the story is less appreciated. With infrastructure in place to strongly accelerate near-term Canadian sales as derivative products come on line, and US optionality to become more visible, we see further upside on a 12-month view. Shareholder dilution has been a risk in the past but we'd like to think this will now be more limited” he writes. Indeed, Bennett also boosted his Aurora price target from C$12 to C$14 (17% upside potential). Support for the move comes from multiple directions, including the recent $175 million transaction for premium cannabis producer Whistler, securing the maximum numbers of lots from the German domestic cultivation tender process, and appointing prominent activist consumer goods investor Nelson Peltz as a strategic advisor. Overall, we can see from TipRanks that Aurora also scores a ‘Moderate Buy’ consensus from the Street. That comes with an average analyst price target of C$13.80 (15% upside potential). See what other Top Analysts are saying about ACB. Best Value Now let’s move from two of the market’s biggest players to two smaller cannabis stocks that could make for savvy short-term investing opportunities. As Bennett writes: “We continue to see very good value at CannTrust and TGOD”: Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF)Green Organic is positioning itself to be the dominant player in the very attractive organic segment. Through its subsidiaries, the company produces farm grown and organic cannabis for medical use worldwide. Although a relatively new player, with an IPO in May 2018, the company has put in place all the tools to succeed.“We remain bullish on TGOD and continue to believe it is set up well to succeed” writes Bennett. “If you had to write a business plan entering the cannabis space late as they have done, then TGOD's approach would tick many of the boxes.” Namely: 1) hiring a management team with over 125 years of consumer goods experience; 2) operating in a relatively uncluttered segment (organic) that can command higher price points; and 3) access to robust capacity (enough to support the organic segment).Plus TGOD has also invested ahead in strong derivative infrastructure (i.e. announcing construction of a beverage focused division in June 2018); and invested internationally, for example with the acquisition of HemPoland in the hemp-based CBD space (distribution across 700 locations and 13 countries).However given that it only started shipping at the end of 1Q19, TGOD needs to execute into the rest of the year. “With potential issues with its Hamilton facility now resolved, we see no reason to believe that it won't. If it does then we see strong upside from here.” But- word of warning- this is a stock for the brave. Because if TGDO doesn’t pull through with strong upward momentum on sales across the quarters a sharp selloff is likely.Nonetheless Bennett is feeling confident. He has just increased his price target to C$6.50 from C$6.10 previously. Given the stock is currently trading at just $4.34 this suggests shares can surge by 50% in the coming months. Encouragingly, the Street echoes this optimistic sentiment. TGOD scores a Strong Buy Street consensus with an average analyst price target of C$7.18.See what other Top Analysts are saying about TGOD. CannTrust Holdings Inc (NYSE:CTST) (TSE:TRST) If you haven’t heard of CannTrust Holdings before, listen up. This is a pharmaceutical company that develops and produces medical cannabis for healthcare sectors in Canada. “We think [CannTrust] can be up there with the top global players, yet its multiple is a fraction of global peers” enthuses the Jefferies analyst. He has a C$13 price target on TRST stock (62% upside potential). He believes the company is a very smart, consistent operator with an excellent outlook. “It is one of the strongest medical businesses in Canada, has been performing very well in early rec, is positioned well to capitalise in derivatives (as well as pet care), and has made some shrewd moves internationally (Pharma partnership, European regional operations, US optionality)” explains the analyst. Yet despite the attractive outlook, recent performance has been notably poor (down 30% since Q4 results), with the market reacting to the soft gross margin and negative EBITDA in 4Q. According to Bennett, this is unfair, as management has simply decided to invest for long-term gain rather than short-term profitability by, for example, securing a low cost supply of cannabis for extraction into derivative products and and list on the NYSE. Moreover, in pre-releasing 1Q expectations recently the company moved to reassure investors when it said gross profit margins would return to between 42%-46% (from 35%).Bottom line: “If CannTrust delivers as we expect it to then its valuation looks very appealing at current levels.” This is reflected by the stock’s Moderate Buy analyst consensus and robust average analyst price target. On the Toronto exchange the C$14 price target suggests 75% upside potential; on NYSE the $12.38 figure is 107% above current price levels.See what other Top Analysts are saying about CTST. Enjoy Research Reports on the Stocks in this Article:Aurora Cannabis Inc (ACB) Research ReportCanopy Growth Corp (CGC) Research ReportCannTrust Holdings Inc (CTST) Research ReportGreen Organic Dutchman Holdings Ltd (TGOD) Research Report

  • CNW Group14 days ago

    The Green Organic Dutchman Holdings Ltd. to Release First Quarter 2019 Earnings Results After Market Close on May 14, 2019

    The Green Organic Dutchman Holdings Ltd. to Release First Quarter 2019 Earnings Results After Market Close on May 14, 2019

  • TGOD Settlement with Hamilton City Council for Cannabis Greenhouse Signed and Approved
    CNW Group18 days ago

    TGOD Settlement with Hamilton City Council for Cannabis Greenhouse Signed and Approved

    HAMILTON, ON , May 3, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to confirm that the Hamilton City Council and the Company have finalized and signed a settlement offer, and that the Local Planning Appeal Tribunal approved the settlement at a meeting on May 2, 2019 . The facilities in Ancaster, Ontario will be capable of growing 17,500 kgs of premium certified organic cannabis annually. "This completes this chapter of our journey," said Brian Athaide , CEO of TGOD.

  • CNW Group20 days ago

    The Green Organic Dutchman and Epican Receive Second Retail Licence from the CLA, Announce Opening of Second Retail Dispensary in Jamaica

    MONTEGO BAY, Jamaica , May 1, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TGOD.TO) (TGODF) is pleased to announce, in conjunction with Epican Medicinals ("Epican"), the opening of its second legal cannabis retail store in Jamaica . Located on Montego Bay's "Hip Strip", the flagship location will open for business on May 4, 2019 . Montego Bay is a popular tourist destination and Jamaica's second largest city.

  • CNW Group21 days ago

    TGOD's Extraction Processing Provider Receives Organic Certification

    TORONTO , April 30, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TGOD.TO) (TGODF) is pleased to announce that its Kelowna -based extraction processing services provider, Valens GroWorks Corp. ("Valens"), has obtained its organic certification from Pro-Cert Organic Systems Ltd. "TGOD has been committed to organic since day one. Working with service providers who embrace organic as much as we do is paramount.  I want to congratulate the team at Valens for obtaining their organic certification," commented Brian Athaide , CEO of TGOD.

  • Say Hello to the Marijuana Industry's Secret Weapon
    Motley Fool21 days ago

    Say Hello to the Marijuana Industry's Secret Weapon

    Women are set to reshape the cannabis industry as both consumers and corporate leaders.

  • PR Newswire25 days ago

    TGOD's European Acquisition HemPoland Receives Organic Certification

    TORONTO, April 26, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce that its wholly owned subsidiary, HemPoland, has received organic certification from EKOGWARANCJA PTRE. This organic certification is provided by the Polish Center for Accreditation on authority from the Minister of Agriculture and Rural Development. HemPoland's facilities, production processes and product offerings are now certified organic.

  • Wall Street’s Got A New Marijuana ETF Neighbor To Stoke Pot Investing
    InvestorPlace28 days ago

    Wall Street’s Got A New Marijuana ETF Neighbor To Stoke Pot Investing

    Canada's exchange-traded fund (ETF) market, though growing, is tiny compared to its U.S. counterpart. Not surprising, however, considering the number of listed cannabis-related companies north of the border, Canada is besting its southern neighbor with its growing roster of listed marijuana ETFs.Source: Shutterstock Since late 2017, the ETFMG Alternative Harvest ETF (NYSEARCA:MJ) has had the U.S. marijuana ETF market to itself, but that changed last week with the debut of the AdvisorShares Pure Cannabis ETF (NYSEARCA:YOLO).YOLO's debut means more to the U.S. marijuana ETF space than simply doubling its size. It's that YOLO is the first marijuana ETF in the U.S. to be born as, well, a marijuana ETF. The aforementioned MJ was born as a different fund and converted to a cannabis ETF in late 2017.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 S&P 500 Stocks to Weather the Earnings Storm As well, YOLO is the first marijuana ETF to have "cannabis" in its name. (Don't underestimate the marketing edge that affords.) Finally, YOLO is actively managed, which could give investors refreshed opportunity in the cannabis ETF space. MJ is a passively managed portfolio. Investigating YOLOYOLO "seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities," according to AdvisorShares. "YOLO is designed to fully invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace."The new marijuana ETF debuts at an interesting time for the wider pot stocks market. Broadly speaking, cannabis names have delivered impressive gains this year, but some have recently encountered headwinds as highlighted by a almost 6% loss this month for MJ."Cannabis stocks have been a volatile but largely outperforming group in 2019. Yet Bank of America Merrill Lynch warns that while some companies are living up to the hype, others have risen too far, too fast, and investors could get burned," reported Teresa Rivas in Barron's last week.While YOLO is bound to hold some of the same stocks as MJ, overlap between the two marijuana ETFs is not significant, at least not yet, and the actively managed fund may have more flexibility to target opportunities in the fast-growing cannabidiol (CBD), medical marijuana and hemp markets.As of its debut, the YOLO portfolio included 23 stocks, with none more than 8% of the holdings. The top two names were The Green Organic Dutchman Holdings Ltd. (OTC:TGODF) and Toronto-listed OrganiGram Holdings Inc. (TSXV:OGI.V).Nearly 7% of Americans are already using cannabidiol, placing the potential market opportunity for the much-hyped cannabis compound at $16 billion by 2025, according to a new analysis by Cowen & Co. cited by Fortune in February. * 5 Dividend Stocks Perfect for Retirees Myriad applications for hemp, including animal care, beverage and food, construction materials, furniture, personal care, textiles and more, make hemp exposure potentially desirable for cannabis investors right now and over the long-term. By some estimates, the global hemp market will have experienced compound annual growth of 14% from 2014 through 2025. Bottom Line on YOLOThe bottom line with any new ETF, particularly one as recent as YOLO, is that time will tell if investors will embrace the product. As MJ, with its nearly $1.2 billion in assets under management, confirms, there is appetite for marijuana ETFs in the U.S.YOLO has a modest fee advantage with an annual expense ratio of 0.74%, or $74 on a $10,000 investment. That is one basis point cheaper than MJ and probably not enough to get investors to dump profitable positions in MJ to move over to the new marijuana ETF because those sales would trigger taxable events that will cost more than the savings offered by YOLO over the competing marijuana ETF.For investors who've not yet been involved in a marijuana ETF, YOLO could be worth considering over the near term.Todd Shriber does not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 High-Yielding Dividend Stocks That Won't Wilt * 4 Energy Stocks Soaring as Trump Tightens on Iran * 7 Tech Stocks With Too Much Risk, Not Enough Upside Compare Brokers The post Wall Street's Got A New Marijuana ETF Neighbor To Stoke Pot Investing appeared first on InvestorPlace.

  • ACCESSWIRE29 days ago

    Company with Solution for Indoor Growers Reporting Big Losses

    HENDERSON, NV / ACCESSWIRE / April 22, 2019 / Large indoor cannabis growers have been reporting big losses due to their energy inefficiency. Just yesterday, CLSK released an Edgar filing reporting $20 million in financing in the form of Debenture, the Series B Preferred Stock, the Warrant and the Common Stock. Today we are highlighting: CleanSpark, Inc. (CLSK), The Green Organic Dutchman (TGODF), Emerald Health Therapeutics (EMHTF), Brookfield Renewable Partners L.P. (BEP), and Covanta Holding Corporation (CVA).